Xiaona Fan

Closest collaborators

The 14 strongest of 14 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

1. Hengzhen Li · 3 shared papers, 2024–2025 · strength 0.55
   • Paper TRIM21 Promotes Tumor Growth and Gemcitabine Resistance in Pancreatic Cancer by Inhibiting EPHX1-Mediated Arachidonic A… DOI 10.1002/advs.202413674↗
   • Paper VDR promotes pancreatic cancer progression in vivo by activating CCL20-mediated M2 polarization of tumor associated mac… DOI 10.1186/s12964-024-01578-x↗
   • Paper Nab-paclitaxel plus S-1 followed by gemcitabine-oxaliplatin as first-line alternating sequential treatment of pancreati… DOI 10.1093/oncolo/oyae207↗
2. Changjie Lou · 2 shared papers, 2024–2025 · strength 0.37
   • Paper TRIM21 Promotes Tumor Growth and Gemcitabine Resistance in Pancreatic Cancer by Inhibiting EPHX1-Mediated Arachidonic A… DOI 10.1002/advs.202413674↗
   • Paper Nab-paclitaxel plus S-1 followed by gemcitabine-oxaliplatin as first-line alternating sequential treatment of pancreati… DOI 10.1093/oncolo/oyae207↗
3. Zhiwei Li · 2 shared papers, 2024 · strength 0.34
   • Paper VDR promotes pancreatic cancer progression in vivo by activating CCL20-mediated M2 polarization of tumor associated mac… DOI 10.1186/s12964-024-01578-x↗
   • Paper Nab-paclitaxel plus S-1 followed by gemcitabine-oxaliplatin as first-line alternating sequential treatment of pancreati… DOI 10.1093/oncolo/oyae207↗
4. Yanqiao Zhang · 2 shared papers, 2024 · strength 0.34
   • Paper VDR promotes pancreatic cancer progression in vivo by activating CCL20-mediated M2 polarization of tumor associated mac… DOI 10.1186/s12964-024-01578-x↗
   • Paper Nab-paclitaxel plus S-1 followed by gemcitabine-oxaliplatin as first-line alternating sequential treatment of pancreati… DOI 10.1093/oncolo/oyae207↗
5. Dan Wang · 2 shared papers, 2020–2024 · strength 0.27
   • Paper Nab-paclitaxel plus S-1 followed by gemcitabine-oxaliplatin as first-line alternating sequential treatment of pancreati… DOI 10.1093/oncolo/oyae207↗
   • Paper Preoperative Mean Corpuscular Hemoglobin Concentration, Red Cell Distribution Width As Predictive Markers For Pancreati… DOI 10.21203/rs.3.rs-37763/v1↗
6. Zhiwei Li · 2 shared papers, 2020 · strength 0.22
   • Paper Lower Mean Corpuscular Hemoglobin Concentration is Associated with Favorable Prognosis of Resected Pancreatic Cancer. DOI 10.21203/rs.3.rs-109365/v1↗
   • Paper Preoperative Mean Corpuscular Hemoglobin Concentration, Red Cell Distribution Width As Predictive Markers For Pancreati… DOI 10.21203/rs.3.rs-37763/v1↗
7. Lin Fang · 2 shared papers, 2020 · strength 0.22
   • Paper Lower Mean Corpuscular Hemoglobin Concentration is Associated with Favorable Prognosis of Resected Pancreatic Cancer. DOI 10.21203/rs.3.rs-109365/v1↗
   • Paper Preoperative Mean Corpuscular Hemoglobin Concentration, Red Cell Distribution Width As Predictive Markers For Pancreati… DOI 10.21203/rs.3.rs-37763/v1↗
8. Zhiwei Li · 1 shared paper, 2025 · strength 0.21
   • Paper TRIM21 Promotes Tumor Growth and Gemcitabine Resistance in Pancreatic Cancer by Inhibiting EPHX1-Mediated Arachidonic A… DOI 10.1002/advs.202413674↗
9. Tongsen Zheng · 1 shared paper, 2024 · strength 0.16
   • Paper Nab-paclitaxel plus S-1 followed by gemcitabine-oxaliplatin as first-line alternating sequential treatment of pancreati… DOI 10.1093/oncolo/oyae207↗
10. Yang Ge · 1 shared paper, 2022 · strength 0.16
    • Paper Inhibition of DCLK1 kinase reverses epithelial-mesenchymal transition and restores T-cell activity in pancreatic ductal… DOI 10.1016/j.tranon.2021.101317↗
11. Rui Yan · 1 shared paper, 2022 · strength 0.16
    • Paper Inhibition of DCLK1 kinase reverses epithelial-mesenchymal transition and restores T-cell activity in pancreatic ductal… DOI 10.1016/j.tranon.2021.101317↗
12. Yuanyuan Zhang · 1 shared paper, 2022 · strength 0.16
    • Paper Inhibition of DCLK1 kinase reverses epithelial-mesenchymal transition and restores T-cell activity in pancreatic ductal… DOI 10.1016/j.tranon.2021.101317↗
13. Guangyu An · 1 shared paper, 2022 · strength 0.16
    • Paper Inhibition of DCLK1 kinase reverses epithelial-mesenchymal transition and restores T-cell activity in pancreatic ductal… DOI 10.1016/j.tranon.2021.101317↗
14. Dan Wang · 1 shared paper, 2020 · strength 0.11
    • Paper Lower Mean Corpuscular Hemoglobin Concentration is Associated with Favorable Prognosis of Resected Pancreatic Cancer. DOI 10.21203/rs.3.rs-109365/v1↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.